Indications and uses
prevents and treats nausea, vomiting or dizziness due to motion sickness
prevents and treats nausea, vomiting or dizziness due to motion sickness
Dosage should be taken one hour before travel starts. Adults and children 12 years of age and older: Chew 1-2 tablets once daily or as directed by a doctor Children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor.
store at room temperature
Meclizine HCl, USP 25 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness due to motion sickness
WARNINGS
Do not use in children under 12 years of age unless directed by a doctor.
Ask a doctor before use if you have
glaucoma
a breathing problem such as emphysema or chronic bronchitis
trouble urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
If pregnant or breast-feeding, ask a health professional before use
Keep out of reach of children.
In case of overdose, get medical help or contact the poison control center immediately.
Dosage should be taken one hour before travel starts.
Adults and children 12 years of age and older: Chew 1-2 tablets once daily or as directed by a doctor
Children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor.
store at room temperature
Phenylketonurics: Contains phenylalanine 0.28 mg per tablet
Do not use if imprinted safety seal under cap is broken or missing
aspartame, croscarmellose sodium, dextrose, FD&C Red #40 Lake, magnesium stearate, maltodextrin, microcrystalline cellulose, natural and artificial flavors, silicon dioxide, sodium sulfate, sugar, tricalcium phosphate.
If you have any questions or comments or to report an adverse event, please contact (800) 795-9775.
When using this product
may cause drowsiness
alcohol, sedatives, and tranquilizers may increase drowsiness
avoid alcoholic drinks
use caution when driving a motor vehicle or operating machinery
Antiemetic
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67296-1390-3 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-5192-a426-e053-dadaa90af4c2 | 505f6036-d216-4455-e054-00144ff88e88 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-1390-3 | Meclizine HCl 25 mg | 30 in 1 BOTTLE | TABLET, CHEWABLE | 30 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-1390 | MECLIZINE HCL 25 MG TABLET, CHEWABLE [REDPHARM DRUG, INC.] | 4 | Legacy NDC, 1 package rows | 20200121_505f6036-d216-4455-e054-00144ff88e88.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51645-994-01 | EA - Each | 51645-994 | 094ec1d6-7d2f-47b2-bfba-42e4d43dd5be | 1 | 2016-03-04 |
| 51645-994-10 | EA - Each | 51645-994 | 1e7b29ee-6984-4e20-aacf-83d5b646caee | 1 | 2016-03-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67296-1390 | 67296-1390-3 |
| 51645-994 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| TRICALCIUM PHOSPHATE | K4C08XP666 | IACT |
| ASPARTAME | Z0H242BBR1 | IACT |
| SUCROSE | C151H8M554 | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SODIUM SULFATE | 0YPR65R21J | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9c9f9369-30eb-3cec-e053-2a95a90a8cef | 505f6036-d216-4455-e054-00144ff88e88 | 2020-01-20 | Warnings | 9c9f9369-30eb-3cec-e053-2a95a90a8cef 505f6036-d216-4455-e054-00144ff88e88 |
Adverse event summaries are temporarily unavailable. Other product information remains available.